{"hands_on_practices": [{"introduction": "Programmed cell death is not always an internally-driven process; it can be initiated by external cues from neighboring cells. This exercise explores the extrinsic apoptotic pathway, a critical mechanism for tissue sculpting and eliminating specific cells during development. By tracing the molecular domino effect triggered by a death receptor, you will solidify your understanding of how an external signal is transduced into an irreversible command for cellular self-destruction [@problem_id:2329991].", "problem": "In the developing mammalian nervous system, programmed cell death, or apoptosis, is a crucial process for sculpting neural circuits by eliminating excess or improperly connected neurons. One major signaling pathway that mediates this process is the extrinsic apoptotic pathway, often initiated by cell-to-cell contact.\n\nConsider a scenario involving a specific type of neuron that expresses the Fas receptor (a member of the tumor necrosis factor receptor superfamily) on its surface. In its vicinity, an activated astrocyte expresses the corresponding membrane-bound Fas ligand (FasL). When the astrocyte makes physical contact with the neuron, the FasL on the astrocyte binds to the Fas receptor on the neuron. This binding event initiates a signaling cascade within the neuron.\n\nWhich of the following options most accurately describes the sequence of key molecular events that occurs inside the neuron immediately following the binding of FasL, ultimately determining the neuron's fate?\n\nA. Binding of FasL causes Fas receptor trimerization and recruitment of the adapter protein Fas-Associated Death Domain (FADD). FADD then recruits pro-caspase-8, forming the Death-Inducing Signaling Complex (DISC). Within the DISC, pro-caspase-8 is activated, which in turn cleaves and activates executioner caspase-3, leading to apoptosis.\n\nB. Binding of FasL triggers the translocation of the pro-apoptotic protein Bax to the mitochondrial outer membrane. This leads to the release of cytochrome c into the cytoplasm, which complexes with Apoptotic Protease Activating Factor 1 (Apaf-1) and pro-caspase-9 to form the apoptosome, initiating apoptosis.\n\nC. Binding of FasL leads to the recruitment and phosphorylation of Protein Kinase B (Akt). Activated Akt then phosphorylates and inactivates pro-apoptotic proteins, promoting cell survival and inhibiting the apoptotic cascade.\n\nD. Binding of FasL causes the Fas receptor to function as a guanine nucleotide exchange factor for the small G-protein Ras. This activation of Ras initiates the mitogen-activated protein kinase (MAPK) signaling cascade, leading to the transcription of genes that promote neuronal growth and differentiation.\n\nE. Binding of FasL directly activates executioner caspase-3 at the plasma membrane. Activated caspase-3 then translocates to the nucleus where it cleaves and activates inhibitor of apoptosis (IAP) proteins, disassembling the cell.", "solution": "The Fas receptor is a prototypical death receptor in the extrinsic apoptotic pathway. When membrane-bound Fas ligand binds to Fas on the neuron, it induces receptor trimerization. This conformational change exposes the intracellular death domains of Fas, which then recruit the adapter protein FADD via homotypic death domain interactions. FADD, through its death effector domain, recruits pro-caspase-8 molecules to the receptor complex, forming the Death-Inducing Signaling Complex (DISC). Within the DISC, induced proximity facilitates autocatalytic activation (cleavage) of pro-caspase-8 into active caspase-8. Active caspase-8 then cleaves and activates executioner caspases, especially pro-caspase-3, initiating the proteolytic cascade that drives apoptosis.\n\nOption A correctly captures this sequence: Fas trimerization, FADD recruitment, DISC formation with pro-caspase-8, activation of caspase-8, and subsequent activation of caspase-3 leading to apoptosis.\n\nOption B describes the intrinsic (mitochondrial) pathway involving Bax translocation, cytochrome c release, Apaf-1, and pro-caspase-9 apoptosome formation. Although extrinsic signaling via caspase-8 can amplify apoptosis by cleaving Bid to tBid and engaging mitochondria, the immediate and defining steps following Fas engagement are DISC formation and caspase-8 activation, not Bax translocation first.\n\nOption C describes Akt-mediated survival signaling, which is not the canonical consequence of Fas engagement and contradicts the role of Fas as a death receptor.\n\nOption D invokes Ras-MAPK growth signaling. Fas does not act as a guanine nucleotide exchange factor for Ras, and this pathway is unrelated to the canonical extrinsic apoptotic signaling by Fas.\n\nOption E is incorrect because Fas engagement does not directly activate executioner caspase-3; activation proceeds via initiator caspase-8 after DISC assembly.\n\nTherefore, the only answer that accurately describes the key molecular events immediately following FasL binding to Fas is A.", "answer": "$$\\boxed{A}$$", "id": "2329991"}, {"introduction": "The decision for a cell to undergo apoptosis is tightly controlled by a balance of pro- and anti-survival proteins. This practice shifts our focus to the intrinsic pathway and its regulation, challenging you to move beyond pathway diagrams to quantitative prediction [@problem_id:2330025]. Using a hypothetical experimental setup, you will calculate how an anti-apoptotic protein, Bcl-2, dampens the apoptotic signal, a skill essential for interpreting data in molecular neuroscience research.", "problem": "A neurobiology research team is studying apoptosis in primary neuronal cultures. These neurons require a specific neurotrophic factor to survive; its withdrawal triggers the intrinsic apoptotic pathway. The team has two sets of cultures: Group C (Control), which consists of normal neurons, and Group E (Engineered), which consists of neurons that have been genetically modified to stably overexpress the anti-apoptotic protein Bcl-2.\n\nBoth groups are subjected to neurotrophic factor withdrawal to induce apoptosis. After 24 hours, the activity of Caspase-3, a key executioner caspase in the apoptotic cascade, is measured in both groups. The following observations are made:\n\n1.  In healthy neurons grown with the neurotrophic factor, there is a low, basal level of Caspase-3 activity, which we will denote as $A_{basal}$.\n2.  The increase in Caspase-3 activity above this basal level is directly proportional to the amount of cytochrome c released from the mitochondria into the cytosol.\n3.  After 24 hours of factor withdrawal, the total measured Caspase-3 activity in the control neurons (Group C) is found to be 30 times the basal level.\n4.  The overexpression of Bcl-2 in the engineered neurons (Group E) is highly effective, inhibiting 95% of the factor withdrawal-induced cytochrome c release compared to the control neurons.\n\nCalculate the ratio of the total Caspase-3 activity in the engineered neurons (Group E) to that in the control neurons (Group C) after the 24-hour period of neurotrophic factor withdrawal. Report your answer as a decimal rounded to three significant figures.", "solution": "Let the basal Caspase-3 activity be $A_{\\text{basal}}$. Let $R_{C}$ denote the amount of cytochrome c released after factor withdrawal in control neurons and $k$ be the proportionality constant relating cytochrome c release to the increase in Caspase-3 activity above basal.\n\nBy the given proportionality, the withdrawal-induced increase in control neurons is $I_{C} = k R_{C}$. The total Caspase-3 activity in control neurons after 24 hours is\n$$\nA_{C} = A_{\\text{basal}} + I_{C}.\n$$\nGiven $A_{C} = 30 A_{\\text{basal}}$, it follows that\n$$\nA_{\\text{basal}} + I_{C} = 30 A_{\\text{basal}} \\quad \\Rightarrow \\quad I_{C} = 29 A_{\\text{basal}}.\n$$\n\nIn engineered neurons, Bcl-2 inhibits the withdrawal-induced cytochrome c release by $0.95$, so the residual release is $R_{E} = 0.05 R_{C}$. The induced increase in engineered neurons is then\n$$\nI_{E} = k R_{E} = k \\cdot 0.05 R_{C} = 0.05 I_{C}.\n$$\nSubstituting $I_{C} = 29 A_{\\text{basal}}$ gives\n$$\nI_{E} = 0.05 \\times 29 A_{\\text{basal}} = 1.45 A_{\\text{basal}}.\n$$\nHence the total Caspase-3 activity in engineered neurons is\n$$\nA_{E} = A_{\\text{basal}} + I_{E} = A_{\\text{basal}} + 1.45 A_{\\text{basal}} = 2.45 A_{\\text{basal}}.\n$$\n\nThe desired ratio is\n$$\n\\frac{A_{E}}{A_{C}} = \\frac{2.45 A_{\\text{basal}}}{30 A_{\\text{basal}}} = \\frac{49}{600} \\approx 0.0817,\n$$\nrounded to three significant figures.", "answer": "$$\\boxed{0.0817}$$", "id": "2330025"}, {"introduction": "What happens when the primary apoptotic machinery is disabled? Cells have evolved alternative, caspase-independent routes to programmed cell death, such as necroptosis, which is crucial in development and disease. This advanced problem asks you to model the necroptotic cascade initiated by Tumor Necrosis Factor alpha (TNF-$\\alpha$) using the principles of enzyme kinetics [@problem_id:2329975]. By calculating reaction rates, you will gain insight into how quantitative modeling can be used to understand complex and non-canonical signaling pathways.", "problem": "In a cellular neuroscience experiment, a population of cultured neurons is treated with Tumor Necrosis Factor alpha (TNF-$\\alpha$), a potent death ligand. Simultaneously, the cells are exposed to a broad-spectrum pan-caspase inhibitor, which completely blocks all caspase activity. Counterintuitively, the neurons still undergo programmed cell death. Further analysis reveals this death occurs via necroptosis, a caspase-independent pathway.\n\nThe key steps of this necroptotic pathway are modeled as a two-stage enzymatic cascade:\n1.  In the presence of the caspase inhibitor, TNF-$\\alpha$ binding to its receptor leads to the formation of a stable, catalytically active form of Receptor-Interacting Protein Kinase 1 (RIPK1). This process establishes a constant concentration of active RIPK1, denoted as $[RIPK1]_{active}$.\n2.  Active RIPK1 then acts as an enzyme to phosphorylate and activate Receptor-Interacting Protein Kinase 3 (RIPK3). The active RIPK1-RIPK3 complex is known as the necrosome. The formation of the necrosome from its substrates follows Michaelis-Menten kinetics with catalytic rate constant $k_{cat,1}$ and Michaelis constant $K_{M,1}$. The active necrosome is also subject to degradation via a first-order process with a rate constant $k_{deg}$.\n3.  The necrosome, in turn, acts as an enzyme to phosphorylate the protein Mixed Lineage Kinase Domain-Like (MLKL). This phosphorylation event activates MLKL, and the resulting phosphorylated MLKL (pMLKL) oligomerizes and forms pores in the plasma membrane, leading to cell lysis. The formation of pMLKL also follows Michaelis-Menten kinetics, with parameters $k_{cat,2}$ and $K_{M,2}$.\n\nAssume that the system reaches a point where the concentration of the active necrosome achieves a steady state. Using the parameters provided below, calculate the initial rate of pMLKL formation.\n\n**Given Parameters:**\n-   Constant concentration of active RIPK1: $[RIPK1]_{active} = 5.00$ nM\n-   Total initial concentration of RIPK3: $[RIPK3]_{total} = 100$ nM\n-   Total initial concentration of MLKL: $[MLKL]_{total} = 400$ nM\n-   RIPK1 kinetic parameters for RIPK3 phosphorylation: $k_{cat,1} = 2.50$ s$^{-1}$, $K_{M,1} = 150$ nM\n-   Necrosome kinetic parameters for MLKL phosphorylation: $k_{cat,2} = 15.0$ s$^{-1}$, $K_{M,2} = 500$ nM\n-   First-order degradation rate constant for the active necrosome: $k_{deg} = 0.500$ s$^{-1}$\n\nExpress your answer for the initial rate of pMLKL formation in units of nM/s, rounded to three significant figures.", "solution": "We denote the active RIPK1 concentration as the constant enzyme concentration for the first step and treat RIPK3 and MLKL as substrates for their respective Michaelis-Menten reactions. The necrosome serves as the enzyme for the second step and is not consumed by catalysis; it is only degraded with first-order rate constant $k_{deg}$. Under the stated assumption, the steady state for the necrosome satisfies formation rate equals degradation rate.\n\nFirst, the necrosome formation rate via RIPK1 acting on RIPK3 is given by Michaelis-Menten kinetics:\n$$\nv_{1}=\\frac{k_{cat,1}\\,[RIPK1]_{active}\\,[RIPK3]_{total}}{K_{M,1}+[RIPK3]_{total}}.\n$$\nAt steady state, the necrosome concentration $[Nec]_{ss}$ satisfies\n$$\n0=\\frac{d[Nec]}{dt}=v_{1}-k_{deg}[Nec]_{ss}\\quad\\Rightarrow\\quad [Nec]_{ss}=\\frac{v_{1}}{k_{deg}}.\n$$\nSubstituting the expression for $v_{1}$,\n$$\n[Nec]_{ss}=\\frac{1}{k_{deg}}\\cdot\\frac{k_{cat,1}\\,[RIPK1]_{active}\\,[RIPK3]_{total}}{K_{M,1}+[RIPK3]_{total}}.\n$$\nThe initial rate of pMLKL formation is then given by Michaelis-Menten kinetics with the necrosome as the enzyme and MLKL as the substrate:\n$$\nv_{2,0}=\\frac{k_{cat,2}\\,[Nec]_{ss}\\,[MLKL]_{total}}{K_{M,2}+[MLKL]_{total}}.\n$$\nSubstitute $[Nec]_{ss}$ from above:\n$$\nv_{2,0}=\\frac{k_{cat,2}}{K_{M,2}+[MLKL]_{total}}\\left(\\frac{1}{k_{deg}}\\cdot\\frac{k_{cat,1}\\,[RIPK1]_{active}\\,[RIPK3]_{total}}{K_{M,1}+[RIPK3]_{total}}\\right)[MLKL]_{total}.\n$$\nNow substitute the given parameter values:\n$$\nv_{1}=\\frac{\\left(2.50\\,\\text{s}^{-1}\\right)\\left(5.00\\,\\text{nM}\\right)\\left(100\\,\\text{nM}\\right)}{150\\,\\text{nM}+100\\,\\text{nM}}=\\frac{1250\\,\\text{nM}^{2}\\,\\text{s}^{-1}}{250\\,\\text{nM}}=5.00\\,\\text{nM}\\,\\text{s}^{-1},\n$$\n$$\n[Nec]_{ss}=\\frac{v_{1}}{k_{deg}}=\\frac{5.00\\,\\text{nM}\\,\\text{s}^{-1}}{0.500\\,\\text{s}^{-1}}=10.0\\,\\text{nM},\n$$\n$$\nv_{2,0}=\\frac{\\left(15.0\\,\\text{s}^{-1}\\right)\\left(10.0\\,\\text{nM}\\right)\\left(400\\,\\text{nM}\\right)}{500\\,\\text{nM}+400\\,\\text{nM}}=\\frac{150\\,\\text{nM}\\,\\text{s}^{-1}\\times 400\\,\\text{nM}}{900\\,\\text{nM}}=150\\,\\text{nM}\\,\\text{s}^{-1}\\times\\frac{4}{9}=66.666\\ldots\\,\\text{nM}\\,\\text{s}^{-1}.\n$$\nRounding to three significant figures gives $66.7$ in units of nM/s.", "answer": "$$\\boxed{66.7}$$", "id": "2329975"}]}